Literature DB >> 15937878

Serial electrophysiologic studies in rhesus monkeys with Krabbe disease.

Maria B Weimer1, Amparo Gutierrez, Gary B Baskin, Juan T Borda, Ronald S Veazey, Leann Myers, Kathrine M Phillippi-Falkenstein, Bruce A Bunnell, Marion S Ratterree, John D England.   

Abstract

Krabbe disease is a progressive leukodystrophy that results in demyelination in the central and peripheral nervous systems in humans. It has been described in a number of mammalian species including the rhesus monkey. We performed serial nerve conduction studies beginning within the first 2 months of life in four homozygous, two heterozygous, and two normal rhesus monkeys (Macaca mulatta) to characterize the peripheral neuropathy. Mean conduction velocities of the median, ulnar, and tibial nerves were significantly slower in the affected than unaffected monkeys at all ages (P < 0.0001). The conduction velocity differences became more apparent between the affected and unaffected as the monkeys aged. When compared to the unaffected monkeys, the serial conduction velocities suggested occurrence of dysmyelination followed by demyelination in the affected monkeys. These observations provide further insight into the disease process and suggest an early window of opportunity for treating Krabbe disease.

Entities:  

Mesh:

Year:  2005        PMID: 15937878     DOI: 10.1002/mus.20350

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).

Authors:  Allison M Bradbury; Jessica H Bagel; Xuntian Jiang; Gary P Swain; Maria L Prociuk; Caitlin A Fitzgerald; Patricia A O'Donnell; Kyle G Braund; Daniel S Ory; Charles H Vite
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 2.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy.

Authors:  Juan T Borda; Xavier Alvarez; Mahesh Mohan; Marion S Ratterree; Kathrine Phillippi-Falkenstein; Andrew A Lackner; Bruce A Bunnell
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

4.  Molecular beacon genotyping for globoid cell leukodystrophy from hair roots in the twitcher mouse and rhesus macaque.

Authors:  Kimberly A Terrell; Terri A Rasmussen; Cyndi Trygg; Bruce A Bunnell; Wayne R Buck
Journal:  J Neurosci Methods       Date:  2007-02-25       Impact factor: 2.390

5.  Sporadic premature aging in a Japanese monkey: a primate model for progeria.

Authors:  Takao Oishi; Hiroo Imai; Yasuhiro Go; Masanori Imamura; Hirohisa Hirai; Masahiko Takada
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

6.  Mesenchymal Stem Cells Yield Transient Improvements in Motor Function in an Infant Rhesus Macaque with Severe Early-Onset Krabbe Disease.

Authors:  Irina A Isakova; Kate C Baker; Jason Dufour; Donald G Phinney
Journal:  Stem Cells Transl Med       Date:  2016-08-24       Impact factor: 6.940

Review 7.  Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases.

Authors:  James C Dodge
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

8.  Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy.

Authors:  Vasco Meneghini; Annalisa Lattanzi; Luigi Tiradani; Gabriele Bravo; Francesco Morena; Francesca Sanvito; Andrea Calabria; John Bringas; Jeanne M Fisher-Perkins; Jason P Dufour; Kate C Baker; Claudio Doglioni; Eugenio Montini; Bruce A Bunnell; Krystof Bankiewicz; Sabata Martino; Luigi Naldini; Angela Gritti
Journal:  EMBO Mol Med       Date:  2016-05-02       Impact factor: 12.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.